jw pharmaceutical jw0061
Scope
Date
~
-
Biotech
JW Bioscience in pancreatic cancer biomarker deal with Immunovia
JW Bioscience Co., a subsidiary of South Korea’s JW Life Science Co., has signed a non-exclusive agreement to transfer its patented technology...
Sep 15, 2021 (Gmt+09:00)
language -
Biotech
Korea’s bio startup Voronoi inks $324 million deal with Brickell Biotech
Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...
Sep 02, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Medicine
JW Pharm exports new antibiotic substance to US
JW Pharmaceutical Co. has become the first South Korean drug maker to develop the generic version of a next-generation antibiotic substance, the med...
Jun 10, 2021 (Gmt+09:00)